Biohub: The Future of Biology Is Open-Source with Co-Founders Mark Zuckerberg, Priscilla Chan, and Head of Science Alex Rives

In a bold move to reshape biomedical research, the Chan Zuckerberg Initiative’s Biohub has pledged $500 million to its Virtual Biology Initiative, an open‑source platform that merges cutting‑edge artificial intelligence with large‑scale wet‑lab data generation. By treating biology as a shared engineering problem, Biohub aims to provide every scientist with the computational tools and high‑resolution datasets needed to model proteins, cells, and eventually whole organisms. This philanthropic scale‑up positions the effort alongside major AI breakthroughs while keeping the output freely accessible.

The core strategy hinges on hierarchical modeling: starting with protein language models that predict folding and function, then scaling to single‑cell transcriptomics, spatial imaging, and multi‑cellular systems. Early successes like the Human Cell Atlas and the community‑driven annotation tool Cell by Gene illustrate how open data pipelines accelerate discovery. Biohub’s labs in San Francisco, New York, and Chicago are inventing novel imaging and sensor technologies to capture data that simply does not exist yet, feeding richer training sets into next‑generation models that can simulate cellular behavior and disease mechanisms.

By coupling frontier AI with frontier biology, Biohub hopes to turn biology from a discovery‑driven discipline into an engineering discipline, enabling researchers to ask digital experiments and extract mechanistic insights from model representations. The open‑source ethos ensures tools spread quickly across academia and industry, maximizing impact far beyond what a traditional venture‑backed biotech could achieve. As mechanistic interpretability advances, these models could reveal unknown protein functions or predict therapeutic targets, ushering in a new era where the entire scientific community co‑creates the foundations of personalized medicine.